Keeping Your Eyes Healthy With Ankylosing Spondylitis

Keeping Your Eyes Healthy With Ankylosing Spondylitis

Keeping Your Eyes Healthy With Ankylosing Spondylitis
Mayara Klingner/Getty Images

Ankylosing spondylitis (AS) is a type of chronic, inflammatory arthritis that primarily affects the joints, ligaments, and tendons of the spine. But it’s also associated with several extra-articular manifestations — or nonjoint conditions or symptoms —including uveitis, the inflammation of the uvea, which is one of the layers of eye tissue that encloses and nourishes the eyeball.

Uveitis typically causes eye pain, redness, blurred vision, and sensitivity to light. These symptoms can come on suddenly or gradually, and anyone who is experiencing them should see an ophthalmologist as soon as possible to prevent irreversible damage to the eye.

The Link Between Eye Inflammation and Ankylosing Spondylitis

Some 20 to 30 percent of people with ankylosing spondylitis develop uveitis at some point. Anterior uveitis, which affects the front parts of the eye, accounts for 90 percent of those cases.

Different types of uveitis affect different parts of the eye, and some are more sight-threatening than others:

  • Anterior uveitis: Also known as iritis, anterior uveitis causes inflammation in front of the lens and behind the cornea.
  • Intermediate uveitis: This mainly develops in the jellylike substance in the middle of the eye, called the vitreous. While severe vision loss is uncommon, visual impairment can occur.

  • Posterior uveitis: This type affects the retina, choroid, and optic nerve, and it can lead to permanent vision loss.

  • Panuveitis: This affects the front, middle, and back of the eye similarly.

James T. Rosenbaum, MD, chair emeritus of the Legacy Devers Eye Institute and member of the Spondylitis Association of America’s Medical and Scientific Advisory Board, says that anterior uveitis has specific characteristics in people with AS.

“With AS, the uveitis is usually anterior and sudden in onset. This results in a red, painful eye that is sensitive to light,” says Dr. Rosenbaum. “Patients with recurrent episodes of anterior uveitis often report a vague sensation that something with the eye is amiss 12 to 24 hours before the eye becomes red.”

He also notes that uveitis is an essential early cue that you should look into whether you might have AS, especially if you have other symptoms that could be explained by AS.

“Uveitis is often the first symptom to prompt the recognition that chronic back pain or a swollen joint or tendon might be part of the AS spectrum,” says Rosenbaum. “If the uveitis began suddenly with redness, pain, and light sensitivity in one eye and then responded promptly to therapy with eye drops, the likelihood of associated AS is especially high.”

Christine Anastasiou, MD, clinical assistant professor in the division of immunology and rheumatology at Stanford Medicine, says that if you have uveitis and the following coinciding symptoms, your doctor may want to explore AS testing:

  • Chronic lower back pain that started before age 45, improves with exercise but not with rest, and persists for more than three months
  • Morning stiffness in the back or hips that lasts more than 30 minutes
  • Reduced flexibility or mobility in the spine or hips
  • A family history of nonradiographic axial spondyloarthritis, psoriasis, or inflammatory bowel disease
  • Joint pain, swelling, or stiffness in the hands and feet
Researchers have found specific genes with links to both ankylosing spondylitis and uveitis. People who develop uveitis and those with AS often share a genetic marker called HLA-B27.

 Another genetic marker with potential links to both conditions may include ERAP1, according to the most recent data available.

These genetic markers may interact in ways that lead to inflammation in different areas of the body.

Rosenbaum explains that testing for HLA-B27 is insufficient for predicting uveitis. “We can test for genes that predispose to uveitis, such as HLA-B27, and we know that local trauma can also trigger an attack,” he says. “But currently, we lack a perfect way to predict who will develop uveitis or when that attack will begin.”

“Although genes like HLA-B27 are strongly linked to AS and uveitis, many people with HLA-B27 never develop the disease,” adds Dr. Anastasiou. “People with a family history of AS are at higher risk to develop AS and associated uveitis.”

Signs and Symptoms of Uveitis

Inflammation associated with uveitis can occur in one or both eyes, potentially leading to the following signs and symptoms:

  • Rapidly developing eye pain
  • Sensitivity to light
  • Eye redness
  • Blurred vision
  • Seeing spots in your vision, known as floaters

The different types of uveitis can cause somewhat different symptoms:

  • Anterior uveitis may cause redness, blurry vision, light sensitivity, and eye pain.
  • Intermediate uveitis symptoms include floaters and blurred vision
  • Posterior uveitis symptoms include difficulties seeing color or a loss of night vision, floaters, reduced visual sharpness, blurred vision, and sensitivity to light.
  • Panuveitis can cause any of these symptoms.

See a doctor immediately if you have any of these signs or symptoms. Without treatment, uveitis can permanently damage the eye.

Diagnosis

Your eye doctor will likely do several tests to determine whether you have uveitis or some other eye problem. You will need to have your eye dilated (widened using special drops) for some of these tests:

  • A vision exam to evaluate your visual acuity and see how your pupils respond to light
  • A slit lamp exam to examine the structures of your eye and look for inflammatory cells
  • Tonometry, to measure the pressure inside your eye (called intraocular pressure)

Uveitis Treatment

With proper treatment, uveitis symptoms should clear up quickly, although the recovery time depends on the severity of the inflammation. It can also become long term, or chronic.

Treatment involves medication, either with steroids to reduce inflammation or with systemic medications that decrease the immune system response that’s contributing to both AS and uveitis.

Steroids

Steroids are a crucial treatment for uveitis. In some cases, prescription eye drops are sufficient to treat it. Steroid treatments include:

  • Prescription steroid eye drops: These may help to reduce inflammation in the eye and include difluprednate (Durezol), dexamethasone (Maxidex, Dexycu), prednisolone acetate (Pred Forte), fluorometholone (Flarex, FML, FML Forte), and loteprednol (Lotemax, Alrex, Inveltys).
  • Steroid implant: An implant in the eye works by releasing steroids slowly over time.

  • Steroid injections in or around the eye: Also known as periocular injections, these might be necessary for people with severe uveitis, individuals with uveitis with fluid buildup and swelling in the eye, or those who can’t use systemic corticosteroids.
  • Systemic steroids: If uveitis is so severe that it risks vision loss or the condition has not responded to eye drops or injections, an ophthalmologist may consider intravenous steroids such as methylprednisolone, or oral steroid medications such as prednisone.

Using steroids comes with a considerable risk of side effects, and the higher the dose and longer an individual takes them, the greater that risk becomes. In the eye, steroid use can lead to increased eye pressure, glaucoma, and cataracts.

Steriods may also increase a person’s risk of the following side effects:

Systemic Therapies

Due to the side effects of corticosteroid use, immunomodulatory therapy or biologic therapies may be used for managing uveitis.

Immunosuppressant drugs, which reduce immune system activity, include:

  • Antimetabolites such as azathioprine, methotrexate, or mycophenolate mofetil
  • Calcineurin inhibitors, including cyclosporine and tacrolimus
  • Alkylating agents, like chlorambucil and cyclophosphamide
Biologic therapies are medications that use genes or complex proteins, targeting specific molecules that play a role in inflammatory or immune-modulated conditions.

“Biologic medications used in AS target specific parts of the immune system that drive inflammation,” explains Dr Anastasiou. “By blocking the pro-inflammatory substances, they reduce inflammation in both the spine and eyes.”

Doctors may prescribe them for treating uveitis that hasn’t responded to other treatments. Biologics include:

  • Anti-interleukin drugs
  • Interferons
  • Intravenous immunoglobulin
  • Janus kinase inhibitors
This may include tumor necrosis factor alpha-blockers, such as infliximab (Remicade), adalimumab (Humira), golimumab (Simponi and Simponi Aria), and certolizumab (Cimzia), which can also reduce ankylosing spondylitis inflammation.

Side effects of biologics include:

  • Infection
  • Allergic reaction
  • Reactivation of some diseases, such as hepatitis B and tuberculosis
  • Central nervous system disorders
  • Cardiac issues
  • Lupus-like syndrome

After you finish treatment for uveitis, you’ll need to be rechecked by an eye doctor — potentially several times — to make sure the condition hasn’t come back, as well as to look for any scarring that may have occurred.

Complications of Uveitis

Complications of uveitis or its treatment include cataracts (clouding of the lens of the eye) and glaucoma (an eye condition that causes damage to the optic nerve).

Cataracts are among the most common uveitis complications, affecting 57 to 78 percent of people with uveitis, depending on the type. They usually develop due to uncontrolled inflammation or in response to treating uveitis with high-dose steroid eye drops or systemic corticosteroids.

 Cataracts may cause the following symptoms:

  • Dim, cloudy, or blurry vision
  • Poor night vision
  • Light sensitivity
  • Needing brighter light during certain activities, such as reading
  • Regular prescription changes for spectacles or contact lenses
  • Colors appearing to fade or become more yellow
  • Double vision in a single eye
American Academy of Ophthalmology guidelines recommend that the eye be as inflammation-free as possible for three months before a surgeon performs a phacoemulsification procedure to remove the cataract.

Scarring from uveitis can weaken a protective barrier in the eye that usually keeps inflammatory cells from entering the fluid-filled chamber in the front of the eye. These cells block the usual channels through which this fluid would drain, causing pressure to build up inside the eye — potentially leading to glaucoma in around 1 in 5 people with uveitis. However, uveitic glaucoma can occur even if eye pressure remains low in a person with uveitis.

Glaucoma often causes no symptoms until the condition has advanced to a later stage, but spotting it early through regular eye checkups can reduce the risk of vision loss. Symptoms of uveitis-related glaucoma might include:

  • Pain
  • Blurred vision
  • Headaches
  • An avoidance of light
  • A colored ring (halo) around vision

Strategies to Protect Your Eyes

The first step is having an eye doctor check out any possible symptoms of eye inflammation.

“Patients with eyes that experience pain, light sensitivity, or a change in the ability to see should consult with a specialist in eye care as soon as possible,” advises Rosenbaum.

He says that starting corticosteroid eye drops as soon as possible after a uveitis episode helps to shorten the attack.

Although uveitis isn’t preventable, the following steps could reduce the risk in some people:

  • Get an annual eye exam: Getting an eye exam every one to two years can help you catch and treat eye issues early.
  • Wear protective eyewear: This guideline applies when you’re in situations that could lead to eye injuries, such as playing contact sports, using power tools, or if your workplace or leisure activities otherwise pose any risk to your eyes.
  • Treat eye infections: This can prevent them from getting worse or spreading.

These precautions may not be enough to prevent uveitis, so it’s important to remain vigilant about any vision changes that occur, especially as a recent episode of uveitis may suggest that another is imminent in some people. “One of the best predictors is having had a prior episode of uveitis, especially if that episode was recent,” says Rosenbaum. “But some individuals have a single episode of uveitis and never have a recurrence.”

The Takeaway

  • The inflammation that causes ankylosing spondylitis can also lead to uveitis, or inflammation of the eye’s middle layer.
  • If you have sudden redness, pain, and light sensitivity in one or both eyes, see an eye specialist as soon as possible.
  • Complications of uveitis and its treatments can include cataracts, glaucoma, and vision loss, so prompt treatment is crucial.
  • Steroids, immunosuppressants, and biologics can treat uveitis, and some biologics can reduce inflammation for both ankylosing spondylitis and uveitis. Discuss your risk of uveitis with the doctor managing your AS.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Wang Y et al. Causal Relationship Between Ankylosing Spondylitis and Ocular Inflammatory Diseases: A Mendelian Randomization Study. Frontiers in Genetics. October 16, 2024.
  2. Uveitis. Johns Hopkins Medicine.
  3. Intermediate Uveitis. American Academy of Ophthalmology. September 19, 2023.
  4. Posterior Uveitis. National Organization for Rare Disorders. April 21, 2021.
  5. Wakefield D et al. Recent Developments in HLA B27 Anterior Uveitis. Frontiers in Immunology. January 5, 2021.
  6. Wakefield D et al. HLA-B27 Anterior Uveitis: Immunology and Immunopathology. Ocular Immunology and Inflammation. May 31, 2016.
  7. Ankylosing Spondylitis. Mayo Clinic. December 21, 2023.
  8. Uveitis. Mayo Clinic. March 7, 2023.
  9. Uveitis. National Eye Institute. December 4, 2024.
  10. Treatment of Uveitis. American Academy of Ophthalmology. December 31, 2023.
  11. Biologic Therapy. National Axial Spondylitis Society.
  12. Ruffing V. Side Effects of Biologic Medications. Johns Hopkins Arthritis Center. January 12, 2016.
  13. Uveitis Cataract. American Academy of Ophthalmology. December 4, 2024.
  14. Cataracts. Mayo Clinic. September 28, 2023.
  15. Uveitic Glaucoma. American Academy of Ophthalmology. September 23, 2024.
  16. Uveitis. Cleveland Clinic. March 25, 2024.
Edmund-Tsui-bio

Edmund Tsui, MD

Medical Reviewer

Edmund Tsui, MD, is an assistant professor of ophthalmology at the Jules Stein Eye Institute in the David Geffen School of Medicine at UCLA.

He earned his medical degree from Dartmouth. He completed an ophthalmology residency at the NYU Grossman School of Medicine, where he was chief resident, followed by a fellowship in uveitis and ocular inflammatory disease at the Francis I. Proctor Foundation for Research in Ophthalmology at the University of California in San Francisco.

Dr. Tsui is committed to advancing the field of ophthalmology. His research focuses on utilizing state-of-the-art ophthalmic imaging technology to improve the diagnosis and monitoring of uveitis. He is a co-investigator in several multicenter clinical trials investigating therapeutics for uveitis. He is the author of over 80 peer-reviewed publications and has given talks at national and international conferences.

Along with his clinical and research responsibilities, Tsui teaches medical students and residents. He is on the Association for Research in Vision and Ophthalmology's professional development and education committee, as well as the advocacy and outreach committee, which seeks to increase funding and awareness of vision research. He also serves on the editorial board of Ophthalmology and the executive committee of the American Uveitis Society.

Adam Felman

Author
Adam is a freelance writer and editor based in Sussex, England. He loves creating content that helps people and animals feel better. His credits include Medical News Today, Greatist, ZOE, MyLifeforce, and Rover, and he also spent a stint as senior updates editor for Screen Rant.

As a hearing aid user and hearing loss advocate, Adam greatly values content that illuminates invisible disabilities. (He's also a music producer and loves the opportunity to explore the junction at which hearing loss and music collide head-on.)

In his spare time, Adam enjoys running along Worthing seafront, hanging out with his rescue dog, Maggie, and performing loop artistry for disgruntled-looking rooms of 10 people or less.